PD44-03 COMPARATIVE EFFECTIVENESS OF SURGICAL TREATMENTS FOR RECURRENT OBSTRUCTION FOLLOWING PYELOPLASTY: A MULTICENTER, PROSPECTIVE STUDY

医学 肾盂成形术 外科 前瞻性队列研究 多中心研究 球囊扩张 普通外科 气球 肾积水 泌尿系统 内科学 随机对照试验
作者
Shengwei Xiong,Hongjian Zhu,Peng Zhang,Bing Wang,Liqun Zhou,Xuesong Li
出处
期刊:The Journal of Urology [Ovid Technologies (Wolters Kluwer)]
卷期号:211 (5S)
标识
DOI:10.1097/01.ju.0001008800.83683.92.03
摘要

You have accessJournal of UrologyReconstruction: Ureteral Reconstruction (Including Pyeloplasty) and Bladder Reconstruction (Including Trauma-Related Fistula) II (PD44)1 May 2024PD44-03 COMPARATIVE EFFECTIVENESS OF SURGICAL TREATMENTS FOR RECURRENT OBSTRUCTION FOLLOWING PYELOPLASTY: A MULTICENTER, PROSPECTIVE STUDY Shengwei Xiong, Hongjian Zhu, Peng Zhang, Bing Wang, Liqun Zhou, and Xuesong Li Shengwei XiongShengwei Xiong , Hongjian ZhuHongjian Zhu , Peng ZhangPeng Zhang , Bing WangBing Wang , Liqun ZhouLiqun Zhou , and Xuesong LiXuesong Li View All Author Informationhttps://doi.org/10.1097/01.JU.0001008800.83683.92.03AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Recurrent ureteropelvic junction obstruction (UPJO) is a relatively rare but challenging condition in clinical practice. This study aims to prospectively compare the effectiveness of different surgical treatments in patients with recurrent UPJO following failed pyeloplasty. METHODS: Patients who underwent subsequent surgical treatments for recurrent UPJO following failed pyeloplasty at four centers were prospectively enrolled starting from May 2020. The patients were grouped based on the type of secondary surgical treatment, including balloon dilation, and robot-assisted dismembered pyeloplasty, flap pyeloplasty, graft ureteroplasty, and ileal ureteral substitution. The choice of surgical treatment was based on factors such as the length of ureteral stricture, and regular follow-up examinations were conducted postoperatively. Surgical outcomes were assessed at 1 year postoperatively. Surgical success was defined as resolution of both clinical symptoms and obstruction on radiographic evaluation. This is a multicenter prospective cohort study that utilized a registry-based research design. Clinical and follow-up data for all enrolled patients were registered in the RECUTTER multicenter database. RESULTS: A total of 255 patients were prospectively enrolled, including 85 balloon dilation, 63 dismembered pyeloplasty, 47 flap pyeloplasty, 27 lingual mucosal graft ureteroplasty, 18 appendiceal onlay flap ureteroplasty, and 5 ileal ureteral substitution. All surgeries were successfully completed without intraoperative complications. The median length of ureteral stricture for the balloon dilation, dismembered pyeloplasty, flap pyeloplasty, lingual mucosal graft ureteroplasty, appendiceal onlay flap ureteroplasty and ileal ureteral substitution were 1 cm, 1.5 cm, 3 cm, 3.5 cm, 3 cm and 5.5 cm, respectively. The median operative time was 75 min, 168 min, 194 min, 200 min, 210 min, and 213.5 min, respectively. The median intraoperative blood loss was 6 mL, 20 mL, 45 mL, 30 mL, 40 mL and 50 mL, respectively. All patients have currently undergone follow-up for more than one year for surgical outcome evaluation. No high-grade complications occurred during the follow-up period. In the balloon dilation group, ten cases (11.8%) were classified as surgical failure; while in the dismembered pyeloplasty group, six cases (9.5%) were classified as surgical failure. For the flap pyeloplasty group, two cases (4.3%) were classified as surgical failure, while no surgical failure was observed in the other groups. CONCLUSIONS: Flap pyeloplasty and graft ureteroplasty demonstrate higher surgical success rates due to their minimal disruption of the ureteral blood supply. Balloon dilation demonstrates favorable early treatment outcomes in patients with shorter ureteral strictures; however, it is associated with a higher recurrence rate. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e905 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Shengwei Xiong More articles by this author Hongjian Zhu More articles by this author Peng Zhang More articles by this author Bing Wang More articles by this author Liqun Zhou More articles by this author Xuesong Li More articles by this author Expand All Advertisement PDF downloadLoading ...

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
十年完成签到 ,获得积分10
5秒前
5秒前
cbb发布了新的文献求助10
11秒前
友好的牛排完成签到,获得积分10
16秒前
三冬四夏完成签到 ,获得积分10
16秒前
David完成签到,获得积分10
20秒前
Edward完成签到 ,获得积分10
21秒前
研友_ZA2B68完成签到,获得积分10
22秒前
coolplex完成签到 ,获得积分10
26秒前
衣蝉完成签到 ,获得积分10
28秒前
小事完成签到 ,获得积分10
34秒前
天边的云彩完成签到 ,获得积分10
35秒前
涛1完成签到 ,获得积分10
36秒前
小墨墨完成签到 ,获得积分10
44秒前
怡然远望完成签到 ,获得积分10
45秒前
cbb完成签到 ,获得积分10
45秒前
奶盐牙牙乐完成签到 ,获得积分10
50秒前
55秒前
lanyetingfeng完成签到 ,获得积分10
56秒前
雪花完成签到 ,获得积分10
58秒前
蓝眸完成签到 ,获得积分10
58秒前
现实的曼安完成签到 ,获得积分10
1分钟前
兔兔完成签到 ,获得积分10
1分钟前
雪山飞龙发布了新的文献求助10
1分钟前
顺利完成签到,获得积分10
1分钟前
雅2018完成签到 ,获得积分0
1分钟前
orixero应助科研通管家采纳,获得10
1分钟前
1分钟前
zcydbttj2011完成签到 ,获得积分10
1分钟前
Beta发布了新的文献求助10
1分钟前
徐新雨完成签到 ,获得积分10
1分钟前
在阳光下完成签到 ,获得积分10
1分钟前
春色未软旧苔痕完成签到 ,获得积分10
2分钟前
淡如水完成签到 ,获得积分10
2分钟前
guang5210完成签到,获得积分10
2分钟前
Tim完成签到 ,获得积分10
2分钟前
2分钟前
黄毛虎完成签到 ,获得积分10
2分钟前
啦啦啦啦完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 400
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3155031
求助须知:如何正确求助?哪些是违规求助? 2805746
关于积分的说明 7865913
捐赠科研通 2464038
什么是DOI,文献DOI怎么找? 1311698
科研通“疑难数据库(出版商)”最低求助积分说明 629728
版权声明 601862